These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38816989)

  • 1. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
    Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.
    Deng Y; Chen X; Chen X; Huang C; Zhang Z; Xu Z; Wang X; Wu J; Li L; Song J; Zhou R
    BMC Cancer; 2024 Sep; 24(1):1158. PubMed ID: 39289660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
    Li Y; Yang X; Lu D
    Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
    Xu D; Wang Z; Li F
    Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling.
    Chen Y; Hong H; Wang Q; Li J; Zhang W; Chen T; Li P
    Cancer Cell Int; 2021 Nov; 21(1):631. PubMed ID: 34838005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway.
    Lu X; Xu X; Zhou M; Ge J; Chen L; Yu W; Wang H
    Cytokine; 2024 Aug; 180():156676. PubMed ID: 38857560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
    Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
    Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.
    Liu S; Liu X; Yang Q; Zeng C; Hu G; Ren B
    J Pharm Pharmacol; 2024 Jul; 76(7):873-883. PubMed ID: 38698658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2.
    Li Z; Zhao PL; Gao X; Li X; Meng YQ; Li ZQ; Zhai KR; Wei SL; Feng HM; Huang HR; Li B
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113043. PubMed ID: 39216120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
    Yu F; Chen Y; Qiu R; Lin N; Yin Y; Zhuo Y; Lin J; Lai F
    Physiol Genomics; 2023 May; 55(5):213-221. PubMed ID: 36939206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
    Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of RNF183 suppressed proliferation of lung adenocarcinoma cells
    Ye G; Luo H; Zhang T; Lan T; Ling B; Qi Z
    Cell Cycle; 2022 May; 21(9):948-960. PubMed ID: 35104174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
    Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
    J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
    Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
    Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation.
    Hu Z; Wu Y; Sun X; Tong Y; Qiu H; Zhuo E
    Biol Direct; 2024 Sep; 19(1):82. PubMed ID: 39285446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
    Zhu J; Ao H; Liu M; Cao K; Ma J
    J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25.
    Zhang W; Yu L; Xu C; Tang T; Cao J; Chen L; Pang X; Ren W
    Cell Biol Int; 2024 Sep; 48(9):1285-1300. PubMed ID: 38894536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.